Member Info for chrishutch

:-)

TIDM: SKIN

RNS Number : 0488G

Integumen PLC

19 July 2019

AIM share code: SKIN

19 July 2019

Integumen PLC

("Integumen" or "Company")

LabskinAI wins new agreements with two Top-10 global cosmetic companies

Integumen today announces that LabskinAI has signed new agreements with two of the Top-10 global cosmetic companies for initial testing on ingredients and products in their portfolio.

These contracts demonstrate an increase in revenue per client as previous clients upgrade from Labskin products purchases to a full virtual service offering and are worth in aggregate in excess of GBP100,000 with the potential for continued testing thereafter. Signed in the first month of H2 2019, these agreements are in addition to the contracts in H1 announced in RNS of 28th May 2019.

Today we also announce that LabskinAI has now completed Beta testing and has fully transitioned from a product sale only company to a virtual and physical test platform for healthcare, personal care, skincare, wound care and pharmaceutical drug discovery eco-system.

LabskinAI contracts, which are EU Regulatory driven, illustrate that LabskinAI virtual services and delivery of physical Labskin services using sophisticated technology integration have the potential to elevate skincare product development. These latest agreements endorse Labskin as an ideal partner to global companies for microbiome testing for consumer skin care products and ingredients.

Gerard Brandon (Chief Executive Officer) commented:

"Integumen is playing a major role in the creation of an innovative AI eco-system that will contribute to the growth of our clients' product range as they develop new skin care products using the LabskinAI virtual platform.

"Right now, LabskinAI serves as a portal for small, medium and large corporations to meet the strict EU regulatory requirements for existing products that are already on the shelf. The repeat custom of two global cosmetic companies is testament to the value of the LabskinAI platform for the entire skin care industry."

This website is not showing it in error, I use sharescope pro for my news feed, prices, and charts but normally this website would show it.

I will copy paste it for you.

yes not showing here

This really is great news for the company.

* New Contracts
* Potential recurring revenue
* Relationships with clients with huge portfolios that will require SKINs services and products.
* LabskinAI has now completed Beta testing and has fully transitioned from a product sale only company to a virtual and physical test platform

When the doors swing open you walk through them.

I think it is partly because it is closing the gap and bouncing off the 20sma before moving up. It is about done and ready for the lunchtime traders to push the price higher.

But trust your research and price will follow we are not in this for a twenty-minute trade. We want much more.

only commercially available

Exactly the potential is huge and not only that but skin

'Labskin’s Fibrin Gel matrix is the only commercially available laboratory-grown full
thickness human skin test platform that creates new collagen production and shows the
impact on your skin’s microflora balance of cosmetic and skin care products.'

TIDM: BRD

RNS Number : 1176G

BlueRock Diamonds PLC

19 July 2019

BlueRock Diamonds PLC / AIM: BRD / Sector: Natural Resources

19 July 2019

BlueRock Diamonds PLC ('BlueRock' or the 'Company')

Sale of 12.2 carat diamond for USD105,000

BlueRock Diamonds plc, the AIM listed diamond mining company, which owns and operates the Kareevlei Diamond Mine in the Kimberley region of South Africa ("Kareevlei"), is pleased to announce that it has sold a 12.2 carat diamond for USD105,000 (USD8,584/carat), in the July tender.

This diamond is the second most valuable diamond the Company has recovered to date, following the sale of a 24.98 carat diamond in the June tender for USD196,000.

Mike Houston, Executive Chairman commented, "We are delighted to have received in excess of USD100,000 for this diamond and continue to be encouraged by the ongoing recovery of high quality stones. We have made excellent progress in improving our operational practises at Kareevlei which has resulted in increased volumes and the more regular recovery of higher value stones."

Market Abuse Regulation (MAR) Disclosure - Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

TIDM: SKIN

RNS Number : 0488G

Integumen PLC

19 July 2019

AIM share code: SKIN

19 July 2019

Integumen PLC

("Integumen" or "Company")

LabskinAI wins new agreements with two Top-10 global cosmetic companies

Integumen today announces that LabskinAI has signed new agreements with two of the Top-10 global cosmetic companies for initial testing on ingredients and products in their portfolio.

These contracts demonstrate an increase in revenue per client as previous clients upgrade from Labskin products purchases to a full virtual service offering and are worth in aggregate in excess of GBP100,000 with the potential for continued testing thereafter. Signed in the first month of H2 2019, these agreements are in addition to the contracts in H1 announced in RNS of 28th May 2019.

Today we also announce that LabskinAI has now completed Beta testing and has fully transitioned from a product sale only company to a virtual and physical test platform for healthcare, personal care, skincare, wound care and pharmaceutical drug discovery eco-system.

LabskinAI contracts, which are EU Regulatory driven, illustrate that LabskinAI virtual services and delivery of physical Labskin services using sophisticated technology integration have the potential to elevate skincare product development. These latest agreements endorse Labskin as an ideal partner to global companies for microbiome testing for consumer skin care products and ingredients.

Gerard Brandon (Chief Executive Officer) commented:

"Integumen is playing a major role in the creation of an innovative AI eco-system that will contribute to the growth of our clients' product range as they develop new skin care products using the LabskinAI virtual platform.

"Right now, LabskinAI serves as a portal for small, medium and large corporations to meet the strict EU regulatory requirements for existing products that are already on the shelf. The repeat custom of two global cosmetic companies is testament to the value of the LabskinAI platform for the entire skin care industry."

Lots talking about the contract wins but we also came out of beta testing. This alone would have been huge news.

The speed at which this company moves forward is very impressive.

A great time to get on board with Integumen as the future really does look special.

New investors: Please spend a bit of time researching the company for yourselves, there is a lot like and multiple products and services. Read the RNS, look over the company wesbsite, watch the numerous videos.

Exciting future ahead.

Yes I saw that and he said 'these clients are two of the Top 10 cosmetics companies in the world, not just another two clients, moving from product sales to recurring full blown LabskinAI services'

It is only the beginning. This is a company that is hallmarked for huge success.

WOW - up we go.

Good to see you back on the board KUMS

exciting times. And a nice bullish chart pattern forming.

soon be above 2p again. So much to like!

https://twitter.com/gjbrandon/status/1151795195501056000